Phase Model of Clinical Care
Phase I
Projected Length: 8 weeks
Minimum Sessions: 16
Minimum Drug Screens: 8
During Phase I, the primary clinical objective is to assist the client in recognizing the impact his/her sustance abuse has had and continues to have on his/her life. The impact of client's use on family and significant other, as well as social interactions, are addressed using evidence-based treatment modalities. Motivational Interviewing and Cognitive Behavioral Therapy are used to assist clients in recognizing for themselves the areas of deficiency that are present in their lives.
Clients are seen twice weekly, once individually and once in a group. Clients who are not admitted for group services will be seen individually twice per week. In order to transition from Phase I to Phase II, clients must be seen face to face for counseling and/or group a minimum of 16 times, taken at least 8 drug screens (of which the last 4 must demonstrate abstinence or harm reduction as identified in their treatment plan) and demonstrate progress in counseling.
Phase II
Projected Length: 8 weeks
Minimum Sessions: 8
Minimum Drug Screens: 8
During Phase II, the primary clinical objective is to assist the client in building on the idenitifcation and recognition of the issues that his/her substance abuse has caused. Clients, through clinical interventions and evidence-based treatment modalities, will work to develop and implement positive, pro-social alternatives to the maladaptive thoughts and behaviors associated with substance abuse. During this phase, clinical support is provided to assist the client in identifying practical, realistic, and achievable alternatives to old thinking and behaviors so as to maximize client's potential for sucess while minimizing barriers to positive transition.
At the conclusion of this phase, the client should be able to pursue employment (if pertinent), consistent participation in ancillary service provision, as well as, compliance with any legal requirements or other obligations of the referal source or outside agencies. Clients are seen twice per month for individual sessions and participate in weekly groups. Clients who are not admitted for group services will be seen once per week individually. In order to transition succesfully from Phase II to Phase III, the client must maintain sobriety verified through 8 drug screens which demonstrate abstinence or harm reduction as identified in their treatment plan.
Phase III
Projected Length: 8 weeks
Minimum Sessions: 4
Minimum Drug Screens: 4
During Phase III, the primary clinical objective is to assist clients in transitioning from active clinical participation to the aftercare portion of treatment. Throughout the duration of the client's participation in the treatment process, the client has had a focus on supportive identification of impairments, as well as, implementation of new thinking and behavior designed to assist client's life functioning. This phase of treatment focuses on assisting the client in transitioning to being able to maintain sobriety without regular clinical intervention through sober support resources developed during treatment, as well as, the use of positive, pro-social coping strategies as developed in treatment.
By transitioning the client in a healthy and responsible mannner through thieir teatment program, clients in this phase should be able to idenitfy independently and between sessions "triggers," as they arise and implement the coping strategies developed in previous phases. By continuing to process these successess with their counselor, the client is assisted in recognizing that they are implementing the change in their lives. Skills they have developed are now working in contrast to behaviors exhibited in the past that only served to continue the cycle of substance use and addiction. Clients will be seen once per month for indivual sessions and will participate in bi-weekly groups. Clients who were not admitted for group services will be seen twice per week individually. In order for client to succesfully transition from Phase III to Phase IV, the client must maintain sobriety verified through at minimum 4 drug screens which must demonstrate abstinence or harm reduction as identified in their treatment plan.
Phase IV
Projected Length: 8 weeks
Minimum Sessions: 2
Minimum Drug Screens: 2
As the client begins the transition process toward discharge, he/she will develop, in concert with his/her clinician, an aftercare and relapse prevention plan built and designed from the client's strengths, as well as support resources that have been idenitifed, developed, and fosterd during the recovery process. In order to successfully complete this phase, and thus treatment, the client must have completed or consistently demonstrated efficacy in his/her goals of treatment. After completing the PRISM program, the client may continue on the road to recovery by participating in ancillary services, such as mental health, AA/NA, legal, etc. The client must be abstinent at the time of discharge in order to have successfully completed treatment.
By using this "Phase Model", we ensure our client's needs are met in a treatment regimen that has shown maximum efficacy and customized treatment plans so that each client's treatment experience is as unique as he/she is. The use of evidence-based programming in counseling, coupled with evidence-based group curriculum, is the cornerstone of our service provision model. The timetables listed are projections, and client needs dictate the length of each phase. By not only being structured in our approach, but also responsive to the needs and situations of the client, our model empowers our clients in developing, implementing, and maintaning positive pro-social and goal-oriented progression.
